Targeting LINC00152 activates cAMP/Ca(2+)/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.
靶向 LINC00152 可激活 cAMP/Ca(2+)/铁死亡轴,并克服 ER+ 乳腺癌的他莫昔芬耐药性
期刊:
影响因子:
doi:10.1101/2023.11.05.565697
Saatci Ozge, Alam Rashed, Huynh-Dam Kim-Tuyen, Isik Aynur, Uner Meral, Belder Nevin, Ersan Pelin Gulizar, Cetin Metin, Tokat Unal Metin, Gedik Mustafa Emre, Bal Hilal, Sahin Ozlem Sener, Riazalhosseini Yasser, Thieffry Denis, Gautheret Daniel, Ogretmen Besim, Aksoy Sercan, Uner Aysegul, Akyol Aytekin, Sahin Ozgur